211 related articles for article (PubMed ID: 11320529)
1. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
Diav-Citrin O; Okotore B; Lucarelli K; Koren G
Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.
Gur C; Diav-Citrin O; Shechtman S; Arnon J; Ornoy A
Reprod Toxicol; 2004; 18(1):93-101. PubMed ID: 15013068
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome of women exposed to azathioprine during pregnancy.
Goldstein LH; Dolinsky G; Greenberg R; Schaefer C; Cohen-Kerem R; Diav-Citrin O; Malm H; Reuvers-Lodewijks ME; Rost van Tonningen-van Driel MM; Arnon J; Ornoy A; Clementi M; Di Gianantonio E; Koren G; Braunstein R; Berkovitch M
Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):696-701. PubMed ID: 17847119
[TBL] [Abstract][Full Text] [Related]
5. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome after in utero exposure to colchicine.
Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
[TBL] [Abstract][Full Text] [Related]
11. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
[TBL] [Abstract][Full Text] [Related]
12. Fetal outcome following roxithromycin exposure in early pregnancy.
Chun JY; Han JY; Ahn HK; Choi JS; Koong MK; Nava-Ocampo AA; Koren G
J Matern Fetal Neonatal Med; 2006 Mar; 19(3):189-92. PubMed ID: 16690513
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine.
Jones KL; Johnson KA; Dick LM; Felix RJ; Kao KK; Chambers CD
Teratology; 2002 Mar; 65(3):125-30. PubMed ID: 11877776
[TBL] [Abstract][Full Text] [Related]
15. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.
Boskovic R; Wide R; Wolpin J; Bauer DJ; Koren G
Neurology; 2005 Sep; 65(6):807-11. PubMed ID: 16186517
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
Colvin J; Bower C; Dickinson JE; Sokol J
Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Arnon J; Lubart I; Ornoy A
Am J Obstet Gynecol; 2003 Jan; 188(1):282-5. PubMed ID: 12548230
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome following exposure to permethrin and use of teratogen information.
Kennedy D; Hurst V; Konradsdottir E; Einarson A
Am J Perinatol; 2005 Feb; 22(2):87-90. PubMed ID: 15731987
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome following in utero exposure to bisphosphonates.
Levy S; Fayez I; Taguchi N; Han JY; Aiello J; Matsui D; Moretti M; Koren G; Ito S
Bone; 2009 Mar; 44(3):428-30. PubMed ID: 19059370
[TBL] [Abstract][Full Text] [Related]
20. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study.
Berkovitch M; Diav-Citrin O; Greenberg R; Cohen M; Bulkowstein M; Shechtman S; Bortnik O; Arnon J; Ornoy A
Br J Clin Pharmacol; 2004 Sep; 58(3):298-302. PubMed ID: 15327589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
